MY125870A
(en)
*
|
1997-07-25 |
2006-08-30 |
Alza Corp |
Osmotic delivery system flow modulator apparatus and method
|
AU1828599A
(en)
*
|
1997-12-29 |
1999-07-19 |
Alza Corporation |
Osmotic delivery system with membrane plug retention mechanism
|
US7258869B1
(en)
*
|
1999-02-08 |
2007-08-21 |
Alza Corporation |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
|
US7919109B2
(en)
|
1999-02-08 |
2011-04-05 |
Intarcia Therapeutics, Inc. |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
|
BR0115392A
(pt)
*
|
2000-11-03 |
2004-06-15 |
Biomedicines Inc |
Método para o tratamento de uma doença sensìvel a interferona em um animal de sangue quente, método para individualizar as dosagens de uma interferona no tratamento, método para a fabricação de um dispositivo de liberação de efeito terapêutico de longa duração de uma droga ao longo de um perìodo de tempo, e conjunto útil para a ministração de uma quantidade relativamente constante de uma droga
|
EP1345588A2
(de)
*
|
2000-12-29 |
2003-09-24 |
Bausch & Lomb Incorporated |
Arzneistoffabgabesysteme mit verzögerter freisetzung
|
US6756058B2
(en)
*
|
2001-01-03 |
2004-06-29 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices with multiple agents
|
ES2294043T3
(es)
*
|
2001-01-03 |
2008-04-01 |
BAUSCH & LOMB INCORPORATED |
Dispositivos de liberacion prolongada de medicamentos que comprenden nucleos recubiertos de medicamentos.
|
US7163688B2
(en)
*
|
2001-06-22 |
2007-01-16 |
Alza Corporation |
Osmotic implant with membrane and membrane retention means
|
WO2003024357A2
(en)
|
2001-09-14 |
2003-03-27 |
Martin Francis J |
Microfabricated nanopore device for sustained release of therapeutic agent
|
US20030143197A1
(en)
*
|
2001-11-09 |
2003-07-31 |
Moran S. Mark |
Method for treating diseases with omega interferon
|
BR0311897A
(pt)
*
|
2002-06-17 |
2005-04-05 |
Alza Corp |
Sistema de liberação osmótica com mecanismo de potência de impulso de ordem zero inicial compreendendo um agente osmótico disperso no veìculo fluido
|
US20040059228A1
(en)
*
|
2002-09-23 |
2004-03-25 |
Scimed Life Systems, Inc. |
Systems and methods for flushing catheters
|
DE60317822D1
(de)
*
|
2002-10-29 |
2008-01-10 |
Alza Corp |
Stabilisierte feste polypeptidpartikel
|
US7731947B2
(en)
*
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
CA2508124A1
(en)
*
|
2002-12-19 |
2004-07-08 |
Alza Corporation |
Stable, non-aqueous, single-phase gels and formulations thereof for delivery from an implantable device
|
MXPA05010605A
(es)
*
|
2003-03-31 |
2005-11-23 |
Alza Corp |
Bomba osmotica con medios para disipar la presion interna.
|
KR20060002922A
(ko)
*
|
2003-03-31 |
2006-01-09 |
알자 코포레이션 |
비수성 단일 상 비히클 및 이러한 비히클을 이용한 제형
|
KR20050120767A
(ko)
*
|
2003-03-31 |
2005-12-23 |
알자 코포레이션 |
삼투성 전달 시스템 및 삼투성 전달 시스템의 기동 시간감소 방법
|
US20040265351A1
(en)
|
2003-04-10 |
2004-12-30 |
Miller Richard L. |
Methods and compositions for enhancing immune response
|
DE602004026173D1
(de)
*
|
2003-04-29 |
2010-05-06 |
Gen Hospital Corp |
Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimitteln
|
CA2437639C
(en)
*
|
2003-08-11 |
2016-07-05 |
Valera Pharmaceuticals, Inc. |
Long term drug delivery devices with polyurethane based polymers and their manufacture
|
US7858110B2
(en)
|
2003-08-11 |
2010-12-28 |
Endo Pharmaceuticals Solutions, Inc. |
Long term drug delivery devices with polyurethane based polymers and their manufacture
|
US20090208540A1
(en)
*
|
2003-08-11 |
2009-08-20 |
Indevus Pharmaceuticals, Inc. |
Implantable device for the delivery of naltrexone and methods of use thereof
|
KR20060097008A
(ko)
|
2003-09-30 |
2006-09-13 |
알자 코포레이션 |
상승하는 방출 프로파일을 제공하는 삼투압으로 구동되는활성제 전달 장치
|
CA2537811A1
(en)
*
|
2003-10-31 |
2005-05-19 |
Alza Corporation |
Osmotic pump with self-retaining, fast-start membrane plug
|
CN1874763A
(zh)
*
|
2003-11-06 |
2006-12-06 |
阿尔扎公司 |
与可植入渗透泵一起使用的模块化吸入速率减小器
|
US20050175701A1
(en)
*
|
2004-02-10 |
2005-08-11 |
Alza Corporation |
Capillary moderator for osmotic delivery system
|
US20050266087A1
(en)
*
|
2004-05-25 |
2005-12-01 |
Gunjan Junnarkar |
Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium
|
US7117870B2
(en)
*
|
2004-07-26 |
2006-10-10 |
Clarity Corporation |
Lacrimal insert having reservoir with controlled release of medication and method of manufacturing the same
|
US20060045891A1
(en)
*
|
2004-08-24 |
2006-03-02 |
Lovalenti Phillip M |
Density-matched suspension vehicles and pharmaceutical suspensions
|
US20060134176A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Pharmaceutical delivery system and method of use
|
EP2361630A1
(de)
*
|
2005-02-03 |
2011-08-31 |
Intarcia Therapeutics, Inc |
Implantierbares Arzneimittelfreigabesystem Partikel und eine osmotische Pumpe enthaltend
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
US20060216242A1
(en)
*
|
2005-02-03 |
2006-09-28 |
Rohloff Catherine M |
Suspending vehicles and pharmaceutical suspensions for drug dosage forms
|
US7959938B2
(en)
*
|
2005-03-15 |
2011-06-14 |
Intarcia Therapeutics, Inc. |
Polyoxaester suspending vehicles for use with implantable delivery systems
|
US20070015689A1
(en)
|
2005-06-23 |
2007-01-18 |
Alza Corporation |
Complexation of metal ions with polypeptides
|
US20070027105A1
(en)
*
|
2005-07-26 |
2007-02-01 |
Alza Corporation |
Peroxide removal from drug delivery vehicle
|
US7790671B2
(en)
*
|
2005-10-07 |
2010-09-07 |
Codman & Shurtleff, Inc. |
Implantable pump for protein delivery for obesity control by drug infusion into the brain
|
KR101106510B1
(ko)
|
2006-05-30 |
2012-01-20 |
인타르시아 세라퓨틱스 인코포레이티드 |
투피스, 내부채널 삼투압 전달 시스템 유동 조절기
|
MX2009001114A
(es)
*
|
2006-08-09 |
2009-02-10 |
Intarcia Therapeutics Inc |
Sistemas de suministro osmotico y ensambles de piston.
|
RU2440097C2
(ru)
*
|
2007-04-23 |
2012-01-20 |
Интарсия Терапьютикс, Инк. |
Способ лечения диабета ii типа и ожирения, осмотическое устройство для доставки и способ его изготовления
|
FI7960U1
(fi)
|
2007-04-27 |
2008-07-28 |
Bayer Schering Pharma Oy |
Implantoitavan annostelusysteemin membraanikuori
|
EP2240155B1
(de)
|
2008-02-13 |
2012-06-06 |
Intarcia Therapeutics, Inc |
Vorrichtungen, formulierungen und verfahren zur freisetzung mehrerer wirkstoffe
|
BRPI0919465A2
(pt)
*
|
2008-09-30 |
2015-12-01 |
Endo Pharmaceuticals Solutions |
dispositivo implantável para a liberação de risperidona e métodos de uso do mesmo
|
JP2012504139A
(ja)
*
|
2008-09-30 |
2012-02-16 |
エンド ファーマスーティカルズ ソリューションズ インコーポレイテッド. |
ヒストレリン送達用埋め込み可能型装置およびその使用方法
|
CA2738715C
(en)
*
|
2008-10-15 |
2013-07-16 |
Intarcia Therapeutics, Inc. |
Highly concentrated drug particles, formulations, suspensions and uses thereof
|
SI2462246T1
(en)
|
2009-09-28 |
2018-01-31 |
Intarcia Therapeutics, Inc. |
Fast-setting and / or cessation of substantially unchanged delivery of the product
|
JP2013509422A
(ja)
|
2009-10-30 |
2013-03-14 |
シーエヌエス セラピューティクス,インク. |
改良されたニュールツリン分子
|
US8038650B2
(en)
*
|
2010-02-22 |
2011-10-18 |
Microsert Ltd. |
Slow release liquid drug delivery device
|
EP2563380B1
(de)
|
2010-04-26 |
2018-05-30 |
aTyr Pharma, Inc. |
Innovative entdeckung therapeutischer, diagnostischer und antikörperhaltiger zusammensetzungen im zusammenhang mit proteinfragmenten der cysteinyl-trna-synthetase
|
EP2563381B1
(de)
|
2010-04-27 |
2017-08-09 |
aTyr Pharma, Inc. |
Innovative entdeckung therapeutischer, diagnostischer und antikörperhaltiger zusammensetzungen im zusammenhang mit proteinfragmenten von isoleucyl-trna-synthetasen
|
WO2011139853A2
(en)
|
2010-04-28 |
2011-11-10 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases
|
CA2797393C
(en)
|
2010-04-29 |
2020-03-10 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases
|
CA2797374C
(en)
|
2010-04-29 |
2021-02-16 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases
|
US9034321B2
(en)
|
2010-05-03 |
2015-05-19 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases
|
EP2566496B1
(de)
|
2010-05-03 |
2018-02-28 |
aTyr Pharma, Inc. |
Innovative entdeckung therapeutischer, diagnostischer und antikörperhaltiger zusammensetzungen im zusammenhang mit proteinfragmenten von methionyl-trna-synthetasen
|
JP5976638B2
(ja)
|
2010-05-03 |
2016-08-23 |
エータイアー ファーマ, インコーポレイテッド |
アルギニルtRNA合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
|
EP2566499B1
(de)
|
2010-05-04 |
2017-01-25 |
aTyr Pharma, Inc. |
Innovative entdeckung therapeutischer, diagnostischer und antikörperhaltiger zusammensetzungen im zusammenhang mit proteinfragmenten aus einem p38-multi-trna-synthetase-komplex
|
US8945541B2
(en)
|
2010-05-14 |
2015-02-03 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-tRNA synthetases
|
JP6027965B2
(ja)
|
2010-05-17 |
2016-11-16 |
エータイアー ファーマ, インコーポレイテッド |
ロイシルtRNA合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
|
EP2575856B1
(de)
|
2010-05-27 |
2017-08-16 |
aTyr Pharma, Inc. |
Therapeutische, diagnostische und antikörperhaltige zusammensetzungen in zusammenhang mit proteinfragmenten von glutaminyl-trna-synthetasen
|
EP2575857B1
(de)
|
2010-06-01 |
2018-01-24 |
aTyr Pharma, Inc. |
Innovative erkennung therapeutischer, diagnostischer und antikörperhaltiger zusammensetzungen in zusammenhang mit proteinfragmenten von lysyl-trna-synthetasen
|
WO2012021247A2
(en)
|
2010-07-12 |
2012-02-16 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases
|
AU2011293294B2
(en)
|
2010-08-25 |
2016-03-24 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Tyrosyl-tRNA synthetases
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
CN103717210B
(zh)
*
|
2011-06-15 |
2018-04-13 |
友霖生技医药股份有限公司 |
多层式胶囊及其制造方法
|
EP2861522A1
(de)
*
|
2012-06-14 |
2015-04-22 |
Ceramatec, Inc |
Vorrichtung und verfahren zur abgabe von heilflüssigkeiten bei gleichbleibender flussrate
|
US9763984B2
(en)
|
2012-12-21 |
2017-09-19 |
Astellas Institute For Regenerative Medicine |
Methods for production of platelets from pluripotent stem cells and compositions thereof
|
EP3079668A1
(de)
|
2013-12-09 |
2016-10-19 |
Durect Corporation |
Pharmazeutisch aktive wirkstoffkomplexe, polymerkomplexe und zusammensetzungen und verfahren damit
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
EP3302354B1
(de)
|
2015-06-03 |
2023-10-04 |
i2o Therapeutics, Inc. |
Systeme zum einsetzen eines implantats
|
KR20180066252A
(ko)
|
2015-11-05 |
2018-06-18 |
더 제너럴 하스피탈 코포레이션 |
부신척수신경병증의 치료를 위한 abcd1을 코딩하는 핵산 서열의 척추강내 전달
|
EP3733694A1
(de)
|
2016-05-16 |
2020-11-04 |
Intarcia Therapeutics, Inc |
Für den glucagonrezeptor selektive polypeptide und verfahren zu deren verwendung
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
CN110191717A
(zh)
|
2016-10-20 |
2019-08-30 |
佩特通公司 |
向中枢神经系统递送神经保护性多肽的方法
|
MX2019008006A
(es)
|
2017-01-03 |
2019-08-29 |
Intarcia Therapeutics Inc |
Metodos que comprenden la administracion continua de un agonista del receptor de glp-1 y la co-administracion de un farmaco.
|
CN110545838A
(zh)
|
2017-03-08 |
2019-12-06 |
因塔西亚制药公司 |
用于从药物递送装置施用致恶心化合物的设备和方法
|
USD933219S1
(en)
|
2018-07-13 |
2021-10-12 |
Intarcia Therapeutics, Inc. |
Implant removal tool and assembly
|
JP2022504596A
(ja)
|
2018-10-11 |
2022-01-13 |
インターシア セラピューティクス,インコーポレイティド |
ヒトアミリンアナログペプチド及び使用方法
|
JP2023515918A
(ja)
|
2020-01-13 |
2023-04-17 |
デュレクト コーポレーション |
不純物が低減された徐放性薬物送達システム及び関連の方法
|